Acalabrutinib for treating relapsed or refractory mantle cell lymphoma [ID6389] Technology appraisal guidance Acalabrutinib with R-CHOP for untreated non-germinal centre B-cell diffuse large B-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results